nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyltestosterone—Hydrocortisone—psoriasis	0.12	0.37	CrCtD
Methyltestosterone—breast cancer—Dexamethasone—psoriasis	0.11	0.5	CpDpCtD
Methyltestosterone—breast cancer—Betamethasone—psoriasis	0.11	0.5	CpDpCtD
Methyltestosterone—Prednisone—psoriasis	0.104	0.319	CrCtD
Methyltestosterone—Prednisolone—psoriasis	0.101	0.311	CrCtD
Methyltestosterone—SHBG—Hydrocortisone—psoriasis	0.0234	0.135	CbGbCtD
Methyltestosterone—ALB—Acitretin—psoriasis	0.0148	0.0852	CbGbCtD
Methyltestosterone—CYP19A1—Betamethasone—psoriasis	0.0147	0.0847	CbGbCtD
Methyltestosterone—SLCO1A2—Prednisolone—psoriasis	0.0113	0.0654	CbGbCtD
Methyltestosterone—SLCO1A2—Hydrocortisone—psoriasis	0.0107	0.062	CbGbCtD
Methyltestosterone—SLCO1A2—Prednisone—psoriasis	0.0107	0.0618	CbGbCtD
Methyltestosterone—SLCO1A2—Cyclosporine—psoriasis	0.0101	0.0585	CbGbCtD
Methyltestosterone—CYP19A1—Dexamethasone—psoriasis	0.00854	0.0493	CbGbCtD
Methyltestosterone—CYP2B6—Cholecalciferol—psoriasis	0.00814	0.047	CbGbCtD
Methyltestosterone—Fluoxymesterone—Clobetasol propionate—psoriasis	0.00731	0.0294	CrCrCtD
Methyltestosterone—Fludrocortisone—Clobetasol propionate—psoriasis	0.00712	0.0286	CrCrCtD
Methyltestosterone—Prednisone—Clobetasol propionate—psoriasis	0.00712	0.0286	CrCrCtD
Methyltestosterone—ALB—Mycophenolate mofetil—psoriasis	0.00692	0.0399	CbGbCtD
Methyltestosterone—Hydrocortamate—Beclomethasone—psoriasis	0.00677	0.0272	CrCrCtD
Methyltestosterone—SLCO1A2—Dexamethasone—psoriasis	0.00668	0.0386	CbGbCtD
Methyltestosterone—Loteprednol—Clobetasol propionate—psoriasis	0.00661	0.0266	CrCrCtD
Methyltestosterone—Prednisolone—Clobetasol propionate—psoriasis	0.00605	0.0243	CrCrCtD
Methyltestosterone—Eplerenone—Hydrocortisone—psoriasis	0.00598	0.024	CrCrCtD
Methyltestosterone—Fludrocortisone—Fluocinolone Acetonide—psoriasis	0.00554	0.0223	CrCrCtD
Methyltestosterone—ALB—Prednisone—psoriasis	0.00553	0.0319	CbGbCtD
Methyltestosterone—SLCO1A2—Methotrexate—psoriasis	0.00537	0.031	CbGbCtD
Methyltestosterone—Loteprednol—Beclomethasone—psoriasis	0.0053	0.0213	CrCrCtD
Methyltestosterone—Formestane—Hydrocortisone—psoriasis	0.005	0.0201	CrCrCtD
Methyltestosterone—CYP3A4—Calcitriol—psoriasis	0.00486	0.028	CbGbCtD
Methyltestosterone—Prednisolone—Beclomethasone—psoriasis	0.00485	0.0195	CrCrCtD
Methyltestosterone—Dydrogesterone—Hydrocortisone—psoriasis	0.00475	0.0191	CrCrCtD
Methyltestosterone—Drospirenone—Hydrocortisone—psoriasis	0.00475	0.0191	CrCrCtD
Methyltestosterone—Prednisolone—Fluocinolone Acetonide—psoriasis	0.00471	0.0189	CrCrCtD
Methyltestosterone—SLC22A8—Methotrexate—psoriasis	0.00468	0.027	CbGbCtD
Methyltestosterone—Potassium Canrenoate—Hydrocortisone—psoriasis	0.00453	0.0182	CrCrCtD
Methyltestosterone—Spironolactone—Hydrocortisone—psoriasis	0.00453	0.0182	CrCrCtD
Methyltestosterone—Megestrol acetate—Hydrocortisone—psoriasis	0.00414	0.0166	CrCrCtD
Methyltestosterone—Levonorgestrel—Hydrocortisone—psoriasis	0.00414	0.0166	CrCrCtD
Methyltestosterone—Potassium Canrenoate—Prednisone—psoriasis	0.0039	0.0157	CrCrCtD
Methyltestosterone—Medrysone—Hydrocortisone—psoriasis	0.00382	0.0154	CrCrCtD
Methyltestosterone—Danazol—Hydrocortisone—psoriasis	0.00382	0.0154	CrCrCtD
Methyltestosterone—Potassium Canrenoate—Prednisolone—psoriasis	0.0038	0.0153	CrCrCtD
Methyltestosterone—CYP3A4—Methoxsalen—psoriasis	0.00378	0.0218	CbGbCtD
Methyltestosterone—Medroxyprogesterone Acetate—Hydrocortisone—psoriasis	0.00368	0.0148	CrCrCtD
Methyltestosterone—CYP2B6—Dexamethasone—psoriasis	0.00352	0.0203	CbGbCtD
Methyltestosterone—Norethindrone—Hydrocortisone—psoriasis	0.00333	0.0134	CrCrCtD
Methyltestosterone—Hydrocortamate—Hydrocortisone—psoriasis	0.00333	0.0134	CrCrCtD
Methyltestosterone—Danazol—Prednisone—psoriasis	0.00329	0.0132	CrCrCtD
Methyltestosterone—Cortisone acetate—Hydrocortisone—psoriasis	0.00322	0.0129	CrCrCtD
Methyltestosterone—Medrysone—Prednisolone—psoriasis	0.00321	0.0129	CrCrCtD
Methyltestosterone—Testolactone—Dexamethasone—psoriasis	0.0029	0.0117	CrCrCtD
Methyltestosterone—Testolactone—Betamethasone—psoriasis	0.0029	0.0117	CrCrCtD
Methyltestosterone—Fluoxymesterone—Hydrocortisone—psoriasis	0.00287	0.0115	CrCrCtD
Methyltestosterone—Hydrocortamate—Prednisone—psoriasis	0.00286	0.0115	CrCrCtD
Methyltestosterone—Testolactone—Triamcinolone—psoriasis	0.00284	0.0114	CrCrCtD
Methyltestosterone—Testosterone Propionate—Hydrocortisone—psoriasis	0.0028	0.0112	CrCrCtD
Methyltestosterone—Prednisone—Hydrocortisone—psoriasis	0.0028	0.0112	CrCrCtD
Methyltestosterone—Fludrocortisone—Hydrocortisone—psoriasis	0.0028	0.0112	CrCrCtD
Methyltestosterone—Progesterone—Hydrocortisone—psoriasis	0.0028	0.0112	CrCrCtD
Methyltestosterone—Hydrocortamate—Prednisolone—psoriasis	0.00279	0.0112	CrCrCtD
Methyltestosterone—ALB—Methotrexate—psoriasis	0.00278	0.016	CbGbCtD
Methyltestosterone—Cortisone acetate—Prednisone—psoriasis	0.00277	0.0111	CrCrCtD
Methyltestosterone—Cortisone acetate—Prednisolone—psoriasis	0.00271	0.0109	CrCrCtD
Methyltestosterone—Testolactone—Prednisone—psoriasis	0.00269	0.0108	CrCrCtD
Methyltestosterone—Fluoxymesterone—Dexamethasone—psoriasis	0.00267	0.0107	CrCrCtD
Methyltestosterone—Fluoxymesterone—Betamethasone—psoriasis	0.00267	0.0107	CrCrCtD
Methyltestosterone—Testolactone—Prednisolone—psoriasis	0.00263	0.0106	CrCrCtD
Methyltestosterone—Fluoxymesterone—Triamcinolone—psoriasis	0.00261	0.0105	CrCrCtD
Methyltestosterone—Loteprednol—Hydrocortisone—psoriasis	0.0026	0.0104	CrCrCtD
Methyltestosterone—Prednisone—Betamethasone—psoriasis	0.0026	0.0104	CrCrCtD
Methyltestosterone—Fludrocortisone—Betamethasone—psoriasis	0.0026	0.0104	CrCrCtD
Methyltestosterone—Prednisone—Dexamethasone—psoriasis	0.0026	0.0104	CrCrCtD
Methyltestosterone—Fludrocortisone—Dexamethasone—psoriasis	0.0026	0.0104	CrCrCtD
Methyltestosterone—Prednisone—Triamcinolone—psoriasis	0.00254	0.0102	CrCrCtD
Methyltestosterone—Fludrocortisone—Triamcinolone—psoriasis	0.00254	0.0102	CrCrCtD
Methyltestosterone—CYP3A4—Cholecalciferol—psoriasis	0.0025	0.0144	CbGbCtD
Methyltestosterone—Testosterone—Hydrocortisone—psoriasis	0.00243	0.00976	CrCrCtD
Methyltestosterone—Fluoxymesterone—Prednisolone—psoriasis	0.00242	0.0097	CrCrCtD
Methyltestosterone—Loteprednol—Dexamethasone—psoriasis	0.00241	0.0097	CrCrCtD
Methyltestosterone—Loteprednol—Betamethasone—psoriasis	0.00241	0.0097	CrCrCtD
Methyltestosterone—Fludrocortisone—Prednisone—psoriasis	0.00241	0.00968	CrCrCtD
Methyltestosterone—Prednisolone—Hydrocortisone—psoriasis	0.00238	0.00955	CrCrCtD
Methyltestosterone—Loteprednol—Triamcinolone—psoriasis	0.00236	0.00947	CrCrCtD
Methyltestosterone—Prednisone—Prednisolone—psoriasis	0.00235	0.00945	CrCrCtD
Methyltestosterone—Fludrocortisone—Prednisolone—psoriasis	0.00235	0.00945	CrCrCtD
Methyltestosterone—Progesterone—Prednisolone—psoriasis	0.00235	0.00945	CrCrCtD
Methyltestosterone—Loteprednol—Prednisone—psoriasis	0.00224	0.00899	CrCrCtD
Methyltestosterone—Prednisolone—Dexamethasone—psoriasis	0.00221	0.00887	CrCrCtD
Methyltestosterone—Prednisolone—Betamethasone—psoriasis	0.00221	0.00887	CrCrCtD
Methyltestosterone—Loteprednol—Prednisolone—psoriasis	0.00219	0.00878	CrCrCtD
Methyltestosterone—CYP3A4—Triamcinolone—psoriasis	0.00217	0.0125	CbGbCtD
Methyltestosterone—CYP3A4—Mycophenolate mofetil—psoriasis	0.00217	0.0125	CbGbCtD
Methyltestosterone—Prednisolone—Triamcinolone—psoriasis	0.00216	0.00867	CrCrCtD
Methyltestosterone—Hydrocortisone—Betamethasone—psoriasis	0.00212	0.00851	CrCrCtD
Methyltestosterone—Hydrocortisone—Dexamethasone—psoriasis	0.00212	0.00851	CrCrCtD
Methyltestosterone—Hydrocortisone—Triamcinolone—psoriasis	0.00207	0.00832	CrCrCtD
Methyltestosterone—Prednisolone—Prednisone—psoriasis	0.00205	0.00823	CrCrCtD
Methyltestosterone—Testosterone—Prednisolone—psoriasis	0.00204	0.0082	CrCrCtD
Methyltestosterone—Hydrocortisone—Prednisone—psoriasis	0.00197	0.0079	CrCrCtD
Methyltestosterone—Hydrocortisone—Prednisolone—psoriasis	0.00192	0.00771	CrCrCtD
Methyltestosterone—CYP3A4—Betamethasone—psoriasis	0.00186	0.0107	CbGbCtD
Methyltestosterone—CYP3A4—Prednisolone—psoriasis	0.00184	0.0106	CbGbCtD
Methyltestosterone—CYP3A4—Hydrocortisone—psoriasis	0.00174	0.01	CbGbCtD
Methyltestosterone—CYP3A4—Prednisone—psoriasis	0.00173	0.01	CbGbCtD
Methyltestosterone—CYP3A4—Cyclosporine—psoriasis	0.00164	0.00948	CbGbCtD
Methyltestosterone—Oligospermia—Hydroxyurea—psoriasis	0.00142	0.0475	CcSEcCtD
Methyltestosterone—Polycythaemia—Mycophenolic acid—psoriasis	0.00114	0.0382	CcSEcCtD
Methyltestosterone—Azoospermia—Hydroxyurea—psoriasis	0.00111	0.037	CcSEcCtD
Methyltestosterone—CYP3A4—Dexamethasone—psoriasis	0.00108	0.00624	CbGbCtD
Methyltestosterone—Polycythaemia—Mycophenolate mofetil—psoriasis	0.000903	0.0302	CcSEcCtD
Methyltestosterone—Embolism venous—Acitretin—psoriasis	0.000753	0.0251	CcSEcCtD
Methyltestosterone—Polycythaemia—Prednisone—psoriasis	0.000612	0.0204	CcSEcCtD
Methyltestosterone—Oligospermia—Methotrexate—psoriasis	0.000533	0.0178	CcSEcCtD
Methyltestosterone—Hirsutism—Mycophenolic acid—psoriasis	0.00043	0.0144	CcSEcCtD
Methyltestosterone—Azoospermia—Methotrexate—psoriasis	0.000415	0.0139	CcSEcCtD
Methyltestosterone—Haemoglobin—Tazarotene—psoriasis	0.000401	0.0134	CcSEcCtD
Methyltestosterone—Haemorrhage—Tazarotene—psoriasis	0.000399	0.0133	CcSEcCtD
Methyltestosterone—Embolism venous—Prednisolone—psoriasis	0.000364	0.0122	CcSEcCtD
Methyltestosterone—Embolism venous—Hydrocortisone—psoriasis	0.000356	0.0119	CcSEcCtD
Methyltestosterone—Hirsutism—Cyclosporine—psoriasis	0.000348	0.0116	CcSEcCtD
Methyltestosterone—Paraesthesia—Calcipotriol—psoriasis	0.000345	0.0115	CcSEcCtD
Methyltestosterone—Amenorrhoea—Hydroxyurea—psoriasis	0.000339	0.0113	CcSEcCtD
Methyltestosterone—Hirsutism—Mycophenolate mofetil—psoriasis	0.000339	0.0113	CcSEcCtD
Methyltestosterone—Embolism venous—Triamcinolone—psoriasis	0.000335	0.0112	CcSEcCtD
Methyltestosterone—Libido decreased—Calcitriol—psoriasis	0.000334	0.0112	CcSEcCtD
Methyltestosterone—Menstruation irregular—Prednisolone—psoriasis	0.000332	0.0111	CcSEcCtD
Methyltestosterone—Menstruation irregular—Hydrocortisone—psoriasis	0.000324	0.0108	CcSEcCtD
Methyltestosterone—Coagulopathy—Mycophenolic acid—psoriasis	0.000321	0.0107	CcSEcCtD
Methyltestosterone—Hirsutism—Prednisolone—psoriasis	0.000316	0.0106	CcSEcCtD
Methyltestosterone—Hirsutism—Hydrocortisone—psoriasis	0.000309	0.0103	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Calcitriol—psoriasis	0.000307	0.0103	CcSEcCtD
Methyltestosterone—Menstruation irregular—Triamcinolone—psoriasis	0.000305	0.0102	CcSEcCtD
Methyltestosterone—Embolism venous—Dexamethasone—psoriasis	0.000304	0.0102	CcSEcCtD
Methyltestosterone—Embolism venous—Betamethasone—psoriasis	0.000304	0.0102	CcSEcCtD
Methyltestosterone—Alopecia—Clobetasol propionate—psoriasis	0.000299	0.00998	CcSEcCtD
Methyltestosterone—Libido decreased—Acitretin—psoriasis	0.000297	0.00993	CcSEcCtD
Methyltestosterone—Hirsutism—Triamcinolone—psoriasis	0.000291	0.00972	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Mycophenolic acid—psoriasis	0.000284	0.0095	CcSEcCtD
Methyltestosterone—Menstruation irregular—Betamethasone—psoriasis	0.000277	0.00926	CcSEcCtD
Methyltestosterone—Menstruation irregular—Dexamethasone—psoriasis	0.000277	0.00926	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Acitretin—psoriasis	0.000274	0.00914	CcSEcCtD
Methyltestosterone—Embolism venous—Prednisone—psoriasis	0.000265	0.00885	CcSEcCtD
Methyltestosterone—Hirsutism—Betamethasone—psoriasis	0.000264	0.00882	CcSEcCtD
Methyltestosterone—Hirsutism—Dexamethasone—psoriasis	0.000264	0.00882	CcSEcCtD
Methyltestosterone—Coagulopathy—Cyclosporine—psoriasis	0.00026	0.00867	CcSEcCtD
Methyltestosterone—Coagulopathy—Mycophenolate mofetil—psoriasis	0.000253	0.00846	CcSEcCtD
Methyltestosterone—Menstruation irregular—Prednisone—psoriasis	0.000241	0.00806	CcSEcCtD
Methyltestosterone—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.000239	0.08	CbGpPWpGaD
Methyltestosterone—Amenorrhoea—Cyclosporine—psoriasis	0.00023	0.00768	CcSEcCtD
Methyltestosterone—Hirsutism—Prednisone—psoriasis	0.00023	0.00768	CcSEcCtD
Methyltestosterone—Amenorrhoea—Mycophenolate mofetil—psoriasis	0.000224	0.00749	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Mycophenolate mofetil—psoriasis	0.000224	0.00749	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Beclomethasone—psoriasis	0.000219	0.0073	CcSEcCtD
Methyltestosterone—Paraesthesia—Clobetasol propionate—psoriasis	0.000216	0.0072	CcSEcCtD
Methyltestosterone—Haemoglobin—Calcitriol—psoriasis	0.000215	0.0072	CcSEcCtD
Methyltestosterone—Haemorrhage—Calcitriol—psoriasis	0.000214	0.00716	CcSEcCtD
Methyltestosterone—Amenorrhoea—Hydrocortisone—psoriasis	0.000204	0.00683	CcSEcCtD
Methyltestosterone—Haemoglobin—Acitretin—psoriasis	0.000192	0.0064	CcSEcCtD
Methyltestosterone—Haemorrhage—Acitretin—psoriasis	0.000191	0.00637	CcSEcCtD
Methyltestosterone—Gynaecomastia—Cyclosporine—psoriasis	0.000181	0.00604	CcSEcCtD
Methyltestosterone—Gynaecomastia—Mycophenolate mofetil—psoriasis	0.000176	0.00589	CcSEcCtD
Methyltestosterone—Amenorrhoea—Betamethasone—psoriasis	0.000175	0.00583	CcSEcCtD
Methyltestosterone—Amenorrhoea—Dexamethasone—psoriasis	0.000175	0.00583	CcSEcCtD
Methyltestosterone—Angiopathy—Acitretin—psoriasis	0.000173	0.00578	CcSEcCtD
Methyltestosterone—Alopecia—Acitretin—psoriasis	0.000169	0.00563	CcSEcCtD
Methyltestosterone—Alopecia—Fluocinolone Acetonide—psoriasis	0.000168	0.00562	CcSEcCtD
Methyltestosterone—Anxiety—Calcitriol—psoriasis	0.000158	0.00529	CcSEcCtD
Methyltestosterone—Libido decreased—Cyclosporine—psoriasis	0.000158	0.00528	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Calcitriol—psoriasis	0.000152	0.00509	CcSEcCtD
Methyltestosterone—Amenorrhoea—Prednisone—psoriasis	0.000152	0.00508	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Cyclosporine—psoriasis	0.000152	0.00506	CcSEcCtD
Methyltestosterone—Haemoglobin—Hydroxyurea—psoriasis	0.000151	0.00503	CcSEcCtD
Methyltestosterone—Headache—Clobetasol propionate—psoriasis	0.00015	0.00502	CcSEcCtD
Methyltestosterone—Haemorrhage—Hydroxyurea—psoriasis	0.00015	0.005	CcSEcCtD
Methyltestosterone—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.000148	0.0496	CbGpPWpGaD
Methyltestosterone—Disturbance in sexual arousal—Cyclosporine—psoriasis	0.000146	0.00486	CcSEcCtD
Methyltestosterone—Anxiety—Acitretin—psoriasis	0.000141	0.00471	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Prednisolone—psoriasis	0.000138	0.00461	CcSEcCtD
Methyltestosterone—Headache—Beclomethasone—psoriasis	0.000137	0.00457	CcSEcCtD
Methyltestosterone—Angiopathy—Hydroxyurea—psoriasis	0.000136	0.00454	CcSEcCtD
Methyltestosterone—Headache—Fluocinonide—psoriasis	0.000136	0.00453	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Hydrocortisone—psoriasis	0.000135	0.0045	CcSEcCtD
Methyltestosterone—Alopecia—Hydroxyurea—psoriasis	0.000132	0.00442	CcSEcCtD
Methyltestosterone—Nausea—Beclomethasone—psoriasis	0.00013	0.00434	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Triamcinolone—psoriasis	0.000127	0.00424	CcSEcCtD
Methyltestosterone—Haemoglobin—Mycophenolic acid—psoriasis	0.000126	0.00421	CcSEcCtD
Methyltestosterone—Haemorrhage—Mycophenolic acid—psoriasis	0.000125	0.00419	CcSEcCtD
Methyltestosterone—Paraesthesia—Acitretin—psoriasis	0.000122	0.00407	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Betamethasone—psoriasis	0.000115	0.00384	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Dexamethasone—psoriasis	0.000115	0.00384	CcSEcCtD
Methyltestosterone—Angiopathy—Mycophenolic acid—psoriasis	0.000114	0.0038	CcSEcCtD
Methyltestosterone—Alopecia—Mycophenolic acid—psoriasis	0.000111	0.0037	CcSEcCtD
Methyltestosterone—Headache—Methoxsalen—psoriasis	0.000107	0.00358	CcSEcCtD
Methyltestosterone—Haemoglobin—Cyclosporine—psoriasis	0.000102	0.00341	CcSEcCtD
Methyltestosterone—Nausea—Methoxsalen—psoriasis	0.000102	0.00339	CcSEcCtD
Methyltestosterone—Haemorrhage—Cyclosporine—psoriasis	0.000101	0.00339	CcSEcCtD
Methyltestosterone—Gynaecomastia—Methotrexate—psoriasis	9.99e-05	0.00334	CcSEcCtD
Methyltestosterone—Haemoglobin—Mycophenolate mofetil—psoriasis	9.95e-05	0.00332	CcSEcCtD
Methyltestosterone—Haemorrhage—Mycophenolate mofetil—psoriasis	9.9e-05	0.00331	CcSEcCtD
Methyltestosterone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	9.6e-05	0.032	CbGpPWpGaD
Methyltestosterone—Headache—Calcitriol—psoriasis	9.54e-05	0.00319	CcSEcCtD
Methyltestosterone—CYP19A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	9.47e-05	0.0316	CbGpPWpGaD
Methyltestosterone—Haemoglobin—Prednisolone—psoriasis	9.28e-05	0.0031	CcSEcCtD
Methyltestosterone—Anxiety—Mycophenolic acid—psoriasis	9.26e-05	0.00309	CcSEcCtD
Methyltestosterone—Haemorrhage—Prednisolone—psoriasis	9.23e-05	0.00308	CcSEcCtD
Methyltestosterone—Angiopathy—Cyclosporine—psoriasis	9.21e-05	0.00308	CcSEcCtD
Methyltestosterone—Haemoglobin—Hydrocortisone—psoriasis	9.06e-05	0.00303	CcSEcCtD
Methyltestosterone—Nausea—Calcitriol—psoriasis	9.05e-05	0.00302	CcSEcCtD
Methyltestosterone—Haemorrhage—Hydrocortisone—psoriasis	9.02e-05	0.00301	CcSEcCtD
Methyltestosterone—Angiopathy—Mycophenolate mofetil—psoriasis	8.98e-05	0.003	CcSEcCtD
Methyltestosterone—Alopecia—Cyclosporine—psoriasis	8.97e-05	0.003	CcSEcCtD
Methyltestosterone—Alopecia—Mycophenolate mofetil—psoriasis	8.75e-05	0.00292	CcSEcCtD
Methyltestosterone—Haemoglobin—Triamcinolone—psoriasis	8.53e-05	0.00285	CcSEcCtD
Methyltestosterone—Haemorrhage—Triamcinolone—psoriasis	8.49e-05	0.00284	CcSEcCtD
Methyltestosterone—Headache—Acitretin—psoriasis	8.49e-05	0.00284	CcSEcCtD
Methyltestosterone—Headache—Fluocinolone Acetonide—psoriasis	8.47e-05	0.00283	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Methotrexate—psoriasis	8.37e-05	0.0028	CcSEcCtD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—ZMIZ1—psoriasis	8.34e-05	0.0279	CbGpPWpGaD
Methyltestosterone—Nausea—Acitretin—psoriasis	8.05e-05	0.00269	CcSEcCtD
Methyltestosterone—Nausea—Fluocinolone Acetonide—psoriasis	8.03e-05	0.00268	CcSEcCtD
Methyltestosterone—Paraesthesia—Mycophenolic acid—psoriasis	8e-05	0.00267	CcSEcCtD
Methyltestosterone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	7.78e-05	0.026	CbGpPWpGaD
Methyltestosterone—Haemoglobin—Betamethasone—psoriasis	7.74e-05	0.00259	CcSEcCtD
Methyltestosterone—Haemoglobin—Dexamethasone—psoriasis	7.74e-05	0.00259	CcSEcCtD
Methyltestosterone—Haemorrhage—Dexamethasone—psoriasis	7.7e-05	0.00257	CcSEcCtD
Methyltestosterone—Haemorrhage—Betamethasone—psoriasis	7.7e-05	0.00257	CcSEcCtD
Methyltestosterone—Anxiety—Cyclosporine—psoriasis	7.49e-05	0.0025	CcSEcCtD
Methyltestosterone—Anxiety—Mycophenolate mofetil—psoriasis	7.31e-05	0.00244	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Cyclosporine—psoriasis	7.21e-05	0.00241	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Mycophenolate mofetil—psoriasis	7.03e-05	0.00235	CcSEcCtD
Methyltestosterone—Angiopathy—Betamethasone—psoriasis	6.99e-05	0.00234	CcSEcCtD
Methyltestosterone—Angiopathy—Dexamethasone—psoriasis	6.99e-05	0.00234	CcSEcCtD
Methyltestosterone—Alopecia—Dexamethasone—psoriasis	6.81e-05	0.00227	CcSEcCtD
Methyltestosterone—Alopecia—Betamethasone—psoriasis	6.81e-05	0.00227	CcSEcCtD
Methyltestosterone—CYP3A4—Xenobiotics—CYP2S1—psoriasis	6.74e-05	0.0225	CbGpPWpGaD
Methyltestosterone—Haemoglobin—Prednisone—psoriasis	6.74e-05	0.00225	CcSEcCtD
Methyltestosterone—Haemorrhage—Prednisone—psoriasis	6.71e-05	0.00224	CcSEcCtD
Methyltestosterone—Headache—Hydroxyurea—psoriasis	6.67e-05	0.00223	CcSEcCtD
Methyltestosterone—Anxiety—Hydrocortisone—psoriasis	6.66e-05	0.00223	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Prednisolone—psoriasis	6.56e-05	0.00219	CcSEcCtD
Methyltestosterone—Paraesthesia—Cyclosporine—psoriasis	6.47e-05	0.00216	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Hydrocortisone—psoriasis	6.41e-05	0.00214	CcSEcCtD
Methyltestosterone—Nausea—Hydroxyurea—psoriasis	6.32e-05	0.00211	CcSEcCtD
Methyltestosterone—Paraesthesia—Mycophenolate mofetil—psoriasis	6.31e-05	0.00211	CcSEcCtD
Methyltestosterone—AR—Androgen receptor signaling pathway—ZMIZ1—psoriasis	6.17e-05	0.0206	CbGpPWpGaD
Methyltestosterone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	6.16e-05	0.0206	CbGpPWpGaD
Methyltestosterone—AR—Regulation of Androgen receptor activity—REL—psoriasis	6.11e-05	0.0204	CbGpPWpGaD
Methyltestosterone—Angiopathy—Prednisone—psoriasis	6.09e-05	0.00203	CcSEcCtD
Methyltestosterone—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	6.08e-05	0.0203	CbGpPWpGaD
Methyltestosterone—Anaphylactic shock—Triamcinolone—psoriasis	6.03e-05	0.00202	CcSEcCtD
Methyltestosterone—AR—Regulation of Androgen receptor activity—CARM1—psoriasis	6.01e-05	0.0201	CbGpPWpGaD
Methyltestosterone—Alopecia—Prednisone—psoriasis	5.93e-05	0.00198	CcSEcCtD
Methyltestosterone—Paraesthesia—Prednisolone—psoriasis	5.89e-05	0.00197	CcSEcCtD
Methyltestosterone—Paraesthesia—Hydrocortisone—psoriasis	5.75e-05	0.00192	CcSEcCtD
Methyltestosterone—Anxiety—Betamethasone—psoriasis	5.69e-05	0.0019	CcSEcCtD
Methyltestosterone—Anxiety—Dexamethasone—psoriasis	5.69e-05	0.0019	CcSEcCtD
Methyltestosterone—Haemoglobin—Methotrexate—psoriasis	5.64e-05	0.00188	CcSEcCtD
Methyltestosterone—Haemorrhage—Methotrexate—psoriasis	5.61e-05	0.00187	CcSEcCtD
Methyltestosterone—Headache—Mycophenolic acid—psoriasis	5.58e-05	0.00187	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Betamethasone—psoriasis	5.47e-05	0.00183	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Dexamethasone—psoriasis	5.47e-05	0.00183	CcSEcCtD
Methyltestosterone—Paraesthesia—Triamcinolone—psoriasis	5.42e-05	0.00181	CcSEcCtD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—CARM1—psoriasis	5.37e-05	0.0179	CbGpPWpGaD
Methyltestosterone—Nausea—Mycophenolic acid—psoriasis	5.29e-05	0.00177	CcSEcCtD
Methyltestosterone—Angiopathy—Methotrexate—psoriasis	5.09e-05	0.0017	CcSEcCtD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	5.04e-05	0.0168	CbGpPWpGaD
Methyltestosterone—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	5e-05	0.0167	CbGpPWpGaD
Methyltestosterone—Anxiety—Prednisone—psoriasis	4.96e-05	0.00166	CcSEcCtD
Methyltestosterone—Alopecia—Methotrexate—psoriasis	4.96e-05	0.00166	CcSEcCtD
Methyltestosterone—Paraesthesia—Dexamethasone—psoriasis	4.92e-05	0.00164	CcSEcCtD
Methyltestosterone—Paraesthesia—Betamethasone—psoriasis	4.92e-05	0.00164	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Prednisone—psoriasis	4.77e-05	0.00159	CcSEcCtD
Methyltestosterone—AR—Nuclear Receptors—VDR—psoriasis	4.69e-05	0.0156	CbGpPWpGaD
Methyltestosterone—CYP19A1—Ovarian Infertility Genes—VDR—psoriasis	4.63e-05	0.0155	CbGpPWpGaD
Methyltestosterone—Headache—Cyclosporine—psoriasis	4.52e-05	0.00151	CcSEcCtD
Methyltestosterone—Headache—Mycophenolate mofetil—psoriasis	4.41e-05	0.00147	CcSEcCtD
Methyltestosterone—Nausea—Cyclosporine—psoriasis	4.28e-05	0.00143	CcSEcCtD
Methyltestosterone—Paraesthesia—Prednisone—psoriasis	4.28e-05	0.00143	CcSEcCtD
Methyltestosterone—Nausea—Mycophenolate mofetil—psoriasis	4.18e-05	0.0014	CcSEcCtD
Methyltestosterone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	4.17e-05	0.0139	CbGpPWpGaD
Methyltestosterone—CYP19A1—Biological oxidations—CYP2S1—psoriasis	4.13e-05	0.0138	CbGpPWpGaD
Methyltestosterone—Headache—Prednisolone—psoriasis	4.11e-05	0.00137	CcSEcCtD
Methyltestosterone—CYP19A1—Metapathway biotransformation—CYP2S1—psoriasis	4.08e-05	0.0136	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	4.04e-05	0.0135	CbGpPWpGaD
Methyltestosterone—Headache—Hydrocortisone—psoriasis	4.01e-05	0.00134	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Methotrexate—psoriasis	3.98e-05	0.00133	CcSEcCtD
Methyltestosterone—AR—Androgen receptor signaling pathway—CARM1—psoriasis	3.97e-05	0.0133	CbGpPWpGaD
Methyltestosterone—Nausea—Prednisolone—psoriasis	3.9e-05	0.0013	CcSEcCtD
Methyltestosterone—Nausea—Hydrocortisone—psoriasis	3.81e-05	0.00127	CcSEcCtD
Methyltestosterone—Headache—Triamcinolone—psoriasis	3.78e-05	0.00126	CcSEcCtD
Methyltestosterone—AR—Nuclear Receptor transcription pathway—VDR—psoriasis	3.7e-05	0.0124	CbGpPWpGaD
Methyltestosterone—ALB—HDL-mediated lipid transport—APOE—psoriasis	3.67e-05	0.0123	CbGpPWpGaD
Methyltestosterone—Nausea—Triamcinolone—psoriasis	3.58e-05	0.0012	CcSEcCtD
Methyltestosterone—Paraesthesia—Methotrexate—psoriasis	3.58e-05	0.0012	CcSEcCtD
Methyltestosterone—CYP19A1—Tryptophan metabolism—CAT—psoriasis	3.57e-05	0.0119	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	3.48e-05	0.0116	CbGpPWpGaD
Methyltestosterone—Headache—Dexamethasone—psoriasis	3.43e-05	0.00115	CcSEcCtD
Methyltestosterone—Headache—Betamethasone—psoriasis	3.43e-05	0.00115	CcSEcCtD
Methyltestosterone—AR—Nuclear Receptors—PPARG—psoriasis	3.27e-05	0.0109	CbGpPWpGaD
Methyltestosterone—Nausea—Betamethasone—psoriasis	3.25e-05	0.00109	CcSEcCtD
Methyltestosterone—Nausea—Dexamethasone—psoriasis	3.25e-05	0.00109	CcSEcCtD
Methyltestosterone—Headache—Prednisone—psoriasis	2.99e-05	0.000998	CcSEcCtD
Methyltestosterone—AR—SIDS Susceptibility Pathways—RUNX3—psoriasis	2.98e-05	0.00996	CbGpPWpGaD
Methyltestosterone—Nausea—Prednisone—psoriasis	2.83e-05	0.000946	CcSEcCtD
Methyltestosterone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	2.83e-05	0.00945	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	2.8e-05	0.00937	CbGpPWpGaD
Methyltestosterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	2.8e-05	0.00935	CbGpPWpGaD
Methyltestosterone—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	2.76e-05	0.00923	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—CYP2S1—psoriasis	2.65e-05	0.00886	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	2.62e-05	0.00874	CbGpPWpGaD
Methyltestosterone—AR—Nuclear Receptor transcription pathway—PPARG—psoriasis	2.58e-05	0.00862	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	2.56e-05	0.00854	CbGpPWpGaD
Methyltestosterone—Headache—Methotrexate—psoriasis	2.5e-05	0.000834	CcSEcCtD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	2.49e-05	0.00831	CbGpPWpGaD
Methyltestosterone—Nausea—Methotrexate—psoriasis	2.37e-05	0.000791	CcSEcCtD
Methyltestosterone—AR—SIDS Susceptibility Pathways—IL13—psoriasis	2.35e-05	0.00786	CbGpPWpGaD
Methyltestosterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	2.27e-05	0.00758	CbGpPWpGaD
Methyltestosterone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	2.24e-05	0.00748	CbGpPWpGaD
Methyltestosterone—AR—Notch-mediated HES/HEY network—CD4—psoriasis	2.18e-05	0.00729	CbGpPWpGaD
Methyltestosterone—ALB—Lipoprotein metabolism—APOE—psoriasis	2.11e-05	0.00704	CbGpPWpGaD
Methyltestosterone—AR—FOXA1 transcription factor network—JUN—psoriasis	2.06e-05	0.00688	CbGpPWpGaD
Methyltestosterone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.97e-05	0.00659	CbGpPWpGaD
Methyltestosterone—SLC22A8—SLC-mediated transmembrane transport—CP—psoriasis	1.89e-05	0.00632	CbGpPWpGaD
Methyltestosterone—AR—Regulation of Androgen receptor activity—JUN—psoriasis	1.78e-05	0.00593	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—SERPINB8—psoriasis	1.72e-05	0.00574	CbGpPWpGaD
Methyltestosterone—AR—Notch-mediated HES/HEY network—STAT3—psoriasis	1.69e-05	0.00565	CbGpPWpGaD
Methyltestosterone—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	1.68e-05	0.00562	CbGpPWpGaD
Methyltestosterone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	1.64e-05	0.00548	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—TARS—psoriasis	1.64e-05	0.00547	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—IL10—psoriasis	1.47e-05	0.00492	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—CAT—psoriasis	1.44e-05	0.00482	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—CRP—psoriasis	1.41e-05	0.00471	CbGpPWpGaD
Methyltestosterone—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	1.4e-05	0.00468	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—APOE—psoriasis	1.38e-05	0.0046	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—psoriasis	1.37e-05	0.00459	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—IL4—psoriasis	1.33e-05	0.00443	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	1.3e-05	0.00432	CbGpPWpGaD
Methyltestosterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	1.29e-05	0.0043	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—psoriasis	1.28e-05	0.00427	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	1.26e-05	0.00422	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—CYP2S1—psoriasis	1.21e-05	0.00403	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	1.19e-05	0.00397	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—JUN—psoriasis	1.17e-05	0.00392	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—CAT—psoriasis	1.15e-05	0.00383	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—CRP—psoriasis	1.15e-05	0.00383	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.14e-05	0.00382	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—CARM1—psoriasis	1.07e-05	0.00358	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—ICAM1—psoriasis	1.05e-05	0.00352	CbGpPWpGaD
Methyltestosterone—CYP3A4—Tryptophan metabolism—CAT—psoriasis	1.04e-05	0.00347	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—STAT3—psoriasis	1.01e-05	0.00339	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	9.85e-06	0.00329	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	9.62e-06	0.00321	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	9.6e-06	0.00321	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—NDUFA5—psoriasis	9.2e-06	0.00307	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	9.18e-06	0.00307	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—CRP—psoriasis	9.11e-06	0.00304	CbGpPWpGaD
Methyltestosterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.97e-06	0.00299	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.57e-06	0.00286	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	8.55e-06	0.00285	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	8.37e-06	0.0028	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—NDUFA5—psoriasis	8.31e-06	0.00278	CbGpPWpGaD
Methyltestosterone—ALB—SLC-mediated transmembrane transport—CP—psoriasis	8.22e-06	0.00274	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	8.2e-06	0.00274	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	8.15e-06	0.00272	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CXCL8—psoriasis	8.05e-06	0.00269	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—IFNG—psoriasis	8.02e-06	0.00268	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CYP2S1—psoriasis	7.82e-06	0.00261	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.75e-06	0.00259	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—JUN—psoriasis	7.68e-06	0.00257	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—JUN—psoriasis	7.49e-06	0.0025	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—NFKB1—psoriasis	7.4e-06	0.00247	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—NFKB1—psoriasis	7.21e-06	0.00241	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CYP2S1—psoriasis	7.07e-06	0.00236	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	6.71e-06	0.00224	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—NFKB1—psoriasis	6.67e-06	0.00223	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	6.61e-06	0.00221	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—VEGFA—psoriasis	6.54e-06	0.00218	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—VDR—psoriasis	6.4e-06	0.00214	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—TNF—psoriasis	6.38e-06	0.00213	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—IFNG—psoriasis	6.37e-06	0.00213	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	6.37e-06	0.00213	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	6.37e-06	0.00213	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	6.13e-06	0.00205	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	5.78e-06	0.00193	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—TNF—psoriasis	5.61e-06	0.00187	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.56e-06	0.00186	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NDUFA5—psoriasis	5.34e-06	0.00178	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	5.3e-06	0.00177	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—VEGFA—psoriasis	5.19e-06	0.00173	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TNF—psoriasis	5.19e-06	0.00173	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—CARM1—psoriasis	5.16e-06	0.00172	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—IL6—psoriasis	5.15e-06	0.00172	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—TP53—psoriasis	5.07e-06	0.00169	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—ITGAL—psoriasis	4.99e-06	0.00167	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	4.95e-06	0.00165	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.77e-06	0.00159	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TP53—psoriasis	4.58e-06	0.00153	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP2S1—psoriasis	4.54e-06	0.00152	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—IL6—psoriasis	4.52e-06	0.00151	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NDUFA5—psoriasis	4.49e-06	0.0015	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—PPARG—psoriasis	4.46e-06	0.00149	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	4.37e-06	0.00146	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	4.2e-06	0.0014	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.19e-06	0.0014	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—IL6—psoriasis	4.19e-06	0.0014	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—CP—psoriasis	4.18e-06	0.00139	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—TNF—psoriasis	4.12e-06	0.00138	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.1e-06	0.00137	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	3.98e-06	0.00133	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP2S1—psoriasis	3.82e-06	0.00128	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CARM1—psoriasis	3.82e-06	0.00128	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.7e-06	0.00124	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.57e-06	0.00119	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CARM1—psoriasis	3.45e-06	0.00115	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—IL6—psoriasis	3.33e-06	0.00111	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.23e-06	0.00108	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—VDR—psoriasis	3.08e-06	0.00103	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NDUFA5—psoriasis	2.43e-06	0.00081	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CAT—psoriasis	2.35e-06	0.000784	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	2.3e-06	0.000769	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CARM1—psoriasis	2.22e-06	0.00074	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—PPARG—psoriasis	2.15e-06	0.000717	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CAT—psoriasis	2.12e-06	0.000709	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP2S1—psoriasis	2.06e-06	0.000689	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—NOS2—psoriasis	2.05e-06	0.000684	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	2e-06	0.000669	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CARM1—psoriasis	1.87e-06	0.000623	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—APOE—psoriasis	1.82e-06	0.000609	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.74e-06	0.000582	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—APOE—psoriasis	1.65e-06	0.000551	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PPARG—psoriasis	1.59e-06	0.000531	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PPARG—psoriasis	1.44e-06	0.00048	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CAT—psoriasis	1.36e-06	0.000455	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—VEGFA—psoriasis	1.19e-06	0.000396	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CAT—psoriasis	1.15e-06	0.000383	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—APOE—psoriasis	1.06e-06	0.000354	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CARM1—psoriasis	1.01e-06	0.000336	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PPARG—psoriasis	9.23e-07	0.000308	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TP53—psoriasis	8.97e-07	0.000299	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—APOE—psoriasis	8.92e-07	0.000298	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PPARG—psoriasis	7.77e-07	0.000259	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CAT—psoriasis	6.19e-07	0.000207	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—APOE—psoriasis	4.81e-07	0.000161	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PPARG—psoriasis	4.19e-07	0.00014	CbGpPWpGaD
